In This Issue:
• The Asset Class of '06- Equities graduate at the top of the asset classes. We are recommending a 65% weighting.
• In the Limelight
• STARS Status: Changes in S&P analysts' STARS rankings for April 14 through April 21.
• Companies with Steady Profit Margin Growth- The firms listed in the table on page 5 boosted their profit margins in each of the past five years, which included a recession in 2001.
• Big Pharma Curbs Generic Rivals- Payments to dissuade generic firms from challenging patents could help the major drug companies - if the practice remains legal.
• What I Wish I Had Known About Retirement- An Outlookreader, who happens to be a retired newspaper personal finance columnist, muses on the unexpected developments of his post-employment life.
• Put a Few Commodities in Your Portfolio- We think investors can still benefit from rising demand for commodities worldwide.
• Commerce Bank Draws On New Markets- We think this company's expansion into lucrative areas like New York will help it post above-average revenue and earnings growth.
• Harness Our Quant Power-Standard & Poor's Neural Fair Value 25 Portfolio buys what are deemed undervalued issues with superior return potential.

Some of the Companies Featured:
Arrow Electronics
Bell South
Canon
City National
Ebay
Grant Prideco
Hologic
Hydril
Johnson & Johnson
Laboratory Corp. Of America
Pepsi Bottling Group
Quest Diagnostics
Sony
Stryker
Toro
Varian Medical Systems

S&P Information Products

Browse S&P industry research products by category:

S&P Industry Surveys
S&P Industry Stock Reports
The Outlook
Search Engine Survey
Pocket Guides
Power Picks

About Standard & Poor's

Standard & Poor's is one of the world's preeminent providers of credit ratings, and for such globally recognized financial-market indices as the S&P 500®. S&P also provides a wide range of other products and services designed to help individuals and institutions around the world make better-informed financial decisions with greater confidence.